D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation

Groupe Hospitalier de la Rochelle Ré Aunis

Status: Completed

Conditions: Atrial Fibrillation

Treatments: Other: D-dimer assay before ablation of atrial fibrillation

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02199080

2014/P02/001

2013-A01700-45 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation

Enrollment: 2,506 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age> 18 years.
• Patients hospitalized for ablation of atrial fibrillation or symptomatic left flutter
• Patient informed of the study

Exclusion criteria

• Age <18 years.
• Patients under guardianship
• Pregnant woman
• Contraindication to transesophageal echocardiography
• transesophageal echocardiography made in another center as the center of ablation
• Refusal of the patient to participate in the study
• Patient participating in another interventional study in which an intervention related to biomedical research is performed before the transesophageal echocardiography

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

2,506 participants in 1 patient group

Atrial fibrillation

Other group

Description:

D-dimer assay before ablation of atrial fibrillation

Treatment:

Other: D-dimer assay before ablation of atrial fibrillation